Literature DB >> 10194456

Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

A E Singh1, B Romanowski.   

Abstract

Syphilis is a chronic disease with a waxing and waning course, the manifestations of which have been described for centuries. It occurs worldwide, and the incidence varies significantly with geographic location. Transmission is mainly by sexual contact. The causative organism, Treponema pallidum, was first described in 1905, but because of the inability to culture the organism and the limitations of direct microscopy, serologic testing is the mainstay of laboratory diagnosis. The disease has been arbitrarily divided into several stages. The primary stage is defined by a chancre at the site of inoculation. The secondary stage is characterized by a polymorphic rash, lymphadenopathy, and other systemic manifestations. A variable asymptomatic latent period follows, which for epidemiologic purposes is divided into early (<1 year) and late (>1 year) stages. The early stages (primary, secondary, and early latent) are potentially infectious. The tertiary stage is the most destructive and is marked by cardiovascular and neurologic sequelae and gummatous involvement of any organ system. Congenital infection may result in protean early or late manifestations. Unlike many other bacteria causing infectious diseases, the organism remains sensitive to penicillin, and this remains the mainstay of therapy.

Entities:  

Mesh:

Year:  1999        PMID: 10194456      PMCID: PMC88914          DOI: 10.1128/CMR.12.2.187

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  309 in total

1.  New case definition for congenital syphilis reporting.

Authors:  P Zenker
Journal:  Sex Transm Dis       Date:  1991 Jan-Mar       Impact factor: 2.830

2.  Serologic screening for syphilis. Rationale, cost, and realpolitik.

Authors:  G P Schmid
Journal:  Sex Transm Dis       Date:  1996 Jan-Feb       Impact factor: 2.830

3.  Congenital syphilis after maternal treatment with erythromycin.

Authors:  L J Fenton; I J Light
Journal:  Obstet Gynecol       Date:  1976-04       Impact factor: 7.661

4.  Congenital syphilis--New York City, 1986-1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-12-08       Impact factor: 17.586

Review 5.  Congenital syphilis: evaluation and management of neonates born to mothers with reactive serologic tests for syphilis.

Authors:  B J Stoll
Journal:  Pediatr Infect Dis J       Date:  1994-10       Impact factor: 2.129

6.  Simultaneous PCR detection of Haemophilus ducreyi, Treponema pallidum, and herpes simplex virus types 1 and 2 from genital ulcers.

Authors:  K A Orle; C A Gates; D H Martin; B A Body; J B Weiss
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Efficacy of ceftizoxime in the treatment of incubating syphilis in rabbits.

Authors:  H C Korting; R Haag; D Walter; U Riethmüller; M Meurer
Journal:  Chemotherapy       Date:  1993 Sep-Oct       Impact factor: 2.544

8.  Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection.

Authors:  J S Haas; G Bolan; S A Larsen; M J Clement; P Bacchetti; A R Moss
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

9.  Primary syphilis and nonimmune fetal hydrops in a penicillin-allergic woman. A case report.

Authors:  G H ElTabbakh; B R Elejalde; F F Broekhuizen
Journal:  J Reprod Med       Date:  1994-05       Impact factor: 0.142

10.  Molecular characterization of receptor binding proteins and immunogens of virulent Treponema pallidum.

Authors:  J B Baseman; E C Hayes
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  113 in total

1.  Validation of the INNO-LIA syphilis kit as a confirmatory assay for Treponema pallidum antibodies.

Authors:  A Ebel; L Vanneste; M Cardinaels; E Sablon; I Samson; K De Bosschere; F Hulstaert; M Zrein
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 2.  Sodium ion cycle in bacterial pathogens: evidence from cross-genome comparisons.

Authors:  C C Häse; N D Fedorova; M Y Galperin; P A Dibrov
Journal:  Microbiol Mol Biol Rev       Date:  2001-09       Impact factor: 11.056

3.  [HIV-positive patient with multiple ulcers. Lues maligna].

Authors:  A Körber; J Dissemond; U Hillen; M Goos; St Esser
Journal:  Hautarzt       Date:  2003-11       Impact factor: 0.751

4.  Syphilis hospitalisations in Portugal over the last decade.

Authors:  B Sousa-Pinto; A Freitas; C Lisboa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-18       Impact factor: 3.267

5.  Secondary syphilis and HIV.

Authors:  Shagun Dhaliwal; Mahir Patel; Alan Menter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2012-01

6.  Demographic, risk factors and motivations among blood donors with reactive serologic tests for syphilis in São Paulo, Brazil.

Authors:  S C Ferreira; C de Almeida-Neto; A S Nishiya; C D L Oliveira; J E Ferreira; C S Alencar; J E Levi; N A Salles; A Mendrone; E C Sabino
Journal:  Transfus Med       Date:  2014-04-30       Impact factor: 2.019

7.  Concordance Between Laboratory Diagnosed Sexually Transmitted Infections and Self-Reported Measures of Risky Sex by Partner Type Among Rural Ugandan Outpatients.

Authors:  Susan M Kiene; Haruna Lule; Peter Hughes; Rhoda K Wanyenze
Journal:  AIDS Behav       Date:  2017-07

8.  High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.

Authors:  S J Reynolds; A R Risbud; M E Shepherd; A M Rompalo; M V Ghate; S V Godbole; S N Joshi; A D Divekar; R R Gangakhedkar; R C Bollinger; S M Mehendale
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

9.  Autofluorescence imaging in rubella retinopathy.

Authors:  Naomi Goldberg; Jack Chou; Anthony Moore; Stephen Tsang
Journal:  Ocul Immunol Inflamm       Date:  2009 Nov-Dec       Impact factor: 3.070

10.  Laboratory diagnosis of syphilis with automated immunoassays.

Authors:  Antonella Marangoni; Alessandra Moroni; Silvia Accardo; Roberto Cevenini
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.